Silk Road Medical Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $17.56
- Today's High:
- $18.9
- Open Price:
- $18.68
- 52W Low:
- $17.56
- 52W High:
- $58.04
- Prev. Close:
- $18.68
- Volume:
- 533777
Company Statistics
- Market Cap.:
- $764.62 million
- Book Value:
- 4.007
- Revenue TTM:
- $162.87 million
- Operating Margin TTM:
- -32.59%
- Gross Profit TTM:
- $100.76 million
- Profit Margin:
- -32.47%
- Return on Assets TTM:
- -15.57%
- Return on Equity TTM:
- -49.07%
Company Profile
Silk Road Medical Inc had its IPO on 2019-04-04 under the ticker symbol SILK.
The company operates in the Healthcare sector and Medical Devices industry. Silk Road Medical Inc has a staff strength of 414 employees.
Stock update
Shares of Silk Road Medical Inc opened at $18.68 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $17.56 - $18.9, and closed at $17.58.
This is a -5.89% slip from the previous day's closing price.
A total volume of 533,777 shares were traded at the close of the day’s session.
In the last one week, shares of Silk Road Medical Inc have slipped by -10.72%.
Silk Road Medical Inc's Key Ratios
Silk Road Medical Inc has a market cap of $764.62 million, indicating a price to book ratio of 36.7442 and a price to sales ratio of 16.5406.
In the last 12-months Silk Road Medical Inc’s revenue was $162.87 million with a gross profit of $100.76 million and an EBITDA of $-50494000. The EBITDA ratio measures Silk Road Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Silk Road Medical Inc’s operating margin was -32.59% while its return on assets stood at -15.57% with a return of equity of -49.07%.
In Q2, Silk Road Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 36.6%.
Silk Road Medical Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-1.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Silk Road Medical Inc’s profitability.
Silk Road Medical Inc stock is trading at a EV to sales ratio of 16.3422 and a EV to EBITDA ratio of -41.2161. Its price to sales ratio in the trailing 12-months stood at 16.5406.
Silk Road Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $263.36 million
- Total Liabilities
- $24.10 million
- Operating Cash Flow
- $-19158000.00
- Capital Expenditure
- $434000
- Dividend Payout Ratio
- 0%
Silk Road Medical Inc ended 2024 with $263.36 million in total assets and $0 in total liabilities. Its intangible assets were valued at $263.36 million while shareholder equity stood at $155.51 million.
Silk Road Medical Inc ended 2024 with $0 in deferred long-term liabilities, $24.10 million in other current liabilities, 39000.00 in common stock, $-373656000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $28.40 million and cash and short-term investments were $188.36 million. The company’s total short-term debt was $1,669,000 while long-term debt stood at $75.10 million.
Silk Road Medical Inc’s total current assets stands at $233.50 million while long-term investments were $13.88 million and short-term investments were $159.96 million. Its net receivables were $21.53 million compared to accounts payable of $5.34 million and inventory worth $19.07 million.
In 2024, Silk Road Medical Inc's operating cash flow was $-19158000.00 while its capital expenditure stood at $434000.
Comparatively, Silk Road Medical Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $17.58
- 52-Week High
- $58.04
- 52-Week Low
- $17.56
- Analyst Target Price
- $34.13
Silk Road Medical Inc stock is currently trading at $17.58 per share. It touched a 52-week high of $58.04 and a 52-week low of $58.04. Analysts tracking the stock have a 12-month average target price of $34.13.
Its 50-day moving average was $22.03 and 200-day moving average was $38.95 The short ratio stood at 1.58 indicating a short percent outstanding of 0%.
Around 234.8% of the company’s stock are held by insiders while 11578.6% are held by institutions.
Frequently Asked Questions About Silk Road Medical Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.